Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study

Affiliations

• ¹ Department of Oncology and Hematology, University of Milan and ASST Papa Giovanni XXIII, Bergamo, Italy. alessandro.rambaldi@unimi.it.
• ² Hematology Division, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
• ³ Department of Experimental and Clinical Medicine, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.
• ⁴ Department of Hematology, Royal Cornwall Hospital, Truro, UK.
• ⁵ Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
• ⁶ Department of Hematology and Oncology, Medical Center, University of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
• ⁷ Hematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
• ⁸ Oncology-Hematology Department, A.O. "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
• ⁹ Department of Hematology Oncology, Charité' Medical School, Campus Benjamin Franklin, Berlin, Germany.
• ¹⁰ U.O. Hematology, San Bortolo Hospital, Vicenza, Italy.
• ¹¹ Hematology and Stem Cells Transplantation Unit, Campus Bio-Medico, University Hospital, Rome, Italy.
• ¹² U.O. Clinical Hematology, Presidio Ospedaliero "Spirito Santo"-A.S.L. Azienda Sanitaria Locale, Pescara, Italy.
• ¹³ Centre for Medical Education, Queen's University Belfast, Belfast, UK.
• ¹⁴ Service d'Oncologie Hématologie, Hospital Saint Vincent de Paul-GHICL Lille, Lille, France.
• ¹⁵ Service d'Oncologie Hématologie Clinique, CHU Amiens-Hospital Sud, Amiens, France.
• ¹⁶ Mayo Clinic Cancer Center, Scottsdale, AZ, USA.
• ¹⁷ New York University School of Medicine & Perlmutter Cancer Center/ NYU Langone Health, New York, NY, USA.
• ¹⁸ Clinical R&D Department, Italfarmaco S.p.A., Cinisello Balsamo, Italy.